Literature DB >> 21283915

Polymer supported synthesis of novel benzoxazole linked benzimidazoles under microwave conditions: in vitro evaluation of VEGFR-3 kinase inhibition activity.

Kaushik Chanda1, Barnali Maiti, Gorakh S Yellol, Ming-Hsien Chien, Min-Liang Kuo, Chung-Ming Sun.   

Abstract

An efficient soluble polymer-supported method has been developed for the parallel synthesis of substituted benzimidazole linked benzoxazoles using focused microwave irradiation. The key step involves the amidation of 4-hydroxy-3-nitrobenzoic acid with polymer-immobilized o-phenylenediamine. Application of mild acidic conditions promoted the ring closure to furnish the benzimidazole ring. After hydrogenation of the nitro-group to amine, the resulted polymer conjugates underwent efficient ring closure with various alkyl, aryl and heteroaryl isothiocyanates to generate the polymer-bound benzimidazolyl benzoxazoles. The polymer-bound compounds were finally cleaved from the support to furnish benzimidazole linked benzoxazole derivatives. The efficacy of the resultant angular bis-heterocyclic library was studied against vascular endothelial growth factor receptor (VEGFR-3). The preliminary screening of these novel compounds exhibits moderate to high inhibition (IC(50) = 0.56-1.42 μM). This protocol provides an easy access to novel angular bis-heterocycles which have potential for the discovery of novel leads for targeted cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283915     DOI: 10.1039/c0ob00547a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Ionic liquid-supported synthesis of dihydroquinazolines and tetrahydroquinazolines under microwave irradiation.

Authors:  Hai-Yuan Hsu; Chih-Chun Tseng; Banrali Matii; Chung-Ming Sun
Journal:  Mol Divers       Date:  2011-12-17       Impact factor: 2.943

2.  Inhibition of Metastatic Potential in Breast Carcinoma In Vivo and In Vitro through Targeting VEGFRs and FGFRs.

Authors:  Ming-Hsien Chien; Liang-Ming Lee; Michael Hsiao; Lin-Hung Wei; Chih-Hau Chen; Tsung-Ching Lai; Kuo-Tai Hua; Min-Wei Chen; Chung-Ming Sun; Min-Liang Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

3.  Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.

Authors:  Yi-Wen Chang; Chih-Ming Su; Yen-Hao Su; Yuan-Soon Ho; Hui-Huang Lai; Hsin-An Chen; Min-Liang Kuo; Wen-Chun Hung; Ya-Wen Chen; Chih-Hsiung Wu; Pai-Sheng Chen; Jen-Liang Su
Journal:  Oncotarget       Date:  2014-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.